Headaches GLP-1-related headaches occur in a subset of users, typically during the first few weeks or after dose escalation
It is commonly studied in models involving soft tissue repair, gastrointestinal barrier integrity, inflammatory signaling, vascular response, and connective tissue remodeling
Fetching molecular profile 5-Amino-1MQAlso known as: 5-amino-1-methylquinolinium, 5-amino-1-methylquinoline, 5-Amino-1-methylquinolinium compound Mechanism of Action 5-Amino-1MQ functions primarily as an inhibitor of the enzyme nicotinamide-N-methyltransferase (NNMT)
The mechanisms are complementary rather than competitiveGLP-1 reduces energy in, while MOTS-c and 5-Amino-1MQ increase energy out
Researchers discovered it in the 1990s while studying how the stomach protects itself from acid damage
They can last from 15 minutes to several hours and are often described as one of the most painful types of headaches